However, the difference did not reach statistical significance.
← all excerpts
Patients with ASPSCR1-TFE3 fusion achieve better response to ICI based combination therapy among TFE3-rearranged renal cell carcinoma
1
—
—
However, the difference did not reach statistical significance.